It is of interest in some applications to determine whether there is a relationship between a hazard rate function (or a cumulative incidence function) and a mark variable which is only observed at uncensored failure times. We develop nonparametric tests for this problem when the mark variable is continuous. Tests are developed for the null hypothesis that the mark-specific hazard rate is independent of the mark versus ordered and two-sided alternatives expressed in terms of mark-specific hazard functions and mark-specific cumulative incidence functions. The test statistics are based on functionals of a bivariate test process equal to a weighted average of differences between a Nelson-Aalen-type estimator of the mark-specific cumulative hazard function and a nonparametric estimator of this function under the null hypothesis. The weight function in the test process can be chosen so that the test statistics are asymptotically distribution-free. Asymptotically correct critical values are obtained through a simple simulation procedure. The testing procedures are shown to perform well in numerical studies, and are illustrated with an AIDS clinical trial example. Specifically, the tests are used to assess if the instantaneous or absolute risk of treatment failure depends on the amount of accumulation of drug resistance mutations in a subject's HIV virus. This assessment helps guide development of anti-HIV therapies that surmount the problem of drug resistance.
Introduction
Many studies of survival data involve mark variables that are only observed at an endpoint event and it is of interest to investigate whether there is any relationship between the time to endpoint and the mark variable. For example, in a clinical trial of drug regimens for treating HIV infection, the time to treatment failure (typically defined by levels of viral load rising above a threshold (Gilbert et al., 2001a) ) can decrease with increases in a distance measure describing the extent of drug-selected HIV genetic evolution within a patient between baseline and the time of failure. Detecting such an association can help in designing anti-HIV treatments that overcome the problem of drug resistance, which represents one of the greatest barriers to achieving durably efficacious treatment of HIV infection (Hirsch et al., 2000; Yeni et al., 2002) .
In this article we develop tests for detecting whether a mark-specific hazard rate (or cumulative incidence function) depends on the mark, and apply the tests to HIV genetic data collected in an AIDS clinical trial. If we denote the time to endpoint T and the mark variable V, the observable random variables are ðX; d; dVÞ, where X ¼ minfT; Cg, d ¼ IðT CÞ, and C is a censoring random variable that is assumed to be independent of T and V. When the failure time T is observed, d ¼ 1 and the mark V is also observed, whereas if T is censored, the mark is unknown. Statistical interest focuses on the mark-specific hazard rate function
and the cumulative incidence function
with t ranging over a fixed interval [0, s] . If V is discrete, the limit h 2 ! 0 is not needed, and the definitions (1) and (2) simplify respectively, to the discrete causespecific hazard function and the discrete cumulative incidence function, which have received much attention in the competing risks literature. In this article, the mark variable V is assumed to be continuous, in which case the functions (1) and (2) are the natural analogs of their discrete counterparts, with similar interpretations. In particular, kðt; vÞ is the instantaneous risk of failure by a cause V in a small interval ½v; v þ h 2 Þ in the presence of all other causes, and Fðt; vÞ is the probability that failure with V in a small interval ½v; v þ h 2 Þ will occur before the specified time t.
As with the classic competing risks model, the mark-specific hazard relates the cumulative incidence function through the simple formula Fðt; vÞ ¼ R t 0 kðs; vÞS T ðsÞ ds, where S T ðtÞ is the survival function of T. Furthermore, just as the cause-specific hazard functions are the basic estimable quantities when the mark variable is discrete (as pointed out by Prentice et al., 1978) , the mark-specific hazard function (1) is estimable from the available data and forms the basis for inference when the mark variable is continuous. Indeed, the likelihood function under the competing risks data with continuous mark has a similar form and is derived as follows. Assume that the continuous mark variable V has a known bounded support; rescaling V if necessary, this support is taken to be [0, 1]. Let fðt; vÞ be the joint density of ðT; VÞ. Then kðt; vÞ ¼ fðt; vÞ=S T ðtÞ and kðtÞ ¼ R 1 0 kðt; vÞ dv is the overall hazard function of T. The likelihood function given n i.i.d. observations ðX i ; d i ; d i V i Þ, i ¼ 1; . . . ; n from the above model can be expressed in terms of the mark-specific hazard rate as
where Q o denotes the product over the observed failure times, Q c denotes the product over right censored failure times, and each product only applies to the expression immediately in front. These considerations motivate us to develop an inferential procedure based on the function (1).
Our interest centers on testing the null hypothesis H 0 : kðt; vÞ does not depend on v for t 2 ½0; s against the following alternative hypotheses:
with strict inequalities for some t, v 1 , v 2 in both H 1 and H 2 . Equivalently, H 0 can be expressed in terms of the cumulative incidence function Fðt; vÞ not depending on v for t 2 ½0; s. The null hypothesis H 0 can also be written as H 0 : kðt; vÞ ¼ kðtÞ for all t 2 ½0; s and v 2 ½0; 1. Expressed in this way, H 0 is the continuous version of the null hypothesis considered by Aly, Kochar and McKeague (1994) , who developed a test for equality of two discrete cause-specific hazard rates, H 0 : k 1 ðtÞ ¼ k 2 ðtÞ for all t 2 ½0; s.
As for the case of discrete competing risks, the interpretation of inferences on the mark-specific hazard function kðt; vÞ is restricted to actual study conditions (i.e., is 'crude' or 'gross'), and there is no implication that the same inference would be made under a new set of conditions in which, for example, certain causes of failure v were not present. With T v denoting the latent (i.e., notional) failure time for mark v (see Prentice et al., 1978 , for discussion of latent failure times), the assumption of mutual independence of the T v for all v 2 ½0; 1 is needed for kðt; vÞ to possess the stronger interpretation as the hazard function for cause v given that all other causes are inoperative. As in the discrete case, the independence assumption is untestable from the available competing risks data (cf., Tsiatis, 1975) ; additional data such as observations of marks beyond the first failure time are needed. Thus, tests of H 0 have an interpretation in terms of association, and cannot be used for causal inference of the predictive effect of a mark variable on the risk of failure. The fact that the mark variable is only observed simultaneously with failure makes clear the impossibility of causal inference (in the absence of strong untestable assumptions).
In the AIDS clinical trial example, V is a measure of the accumulated HIV genetic resistance resulting from exposure to an antiretroviral treatment, which is measured only on subjects who fail treatment, at the time of treatment failure. The test of H 0 versus the monotone alternative H 1 ðH 2 Þ assesses whether the absolute (instantaneous) risk of treatment failure increases with the level of acquired drug resistance. If V is a reliable measure of the 'resistance cost' of the regimen, i.e., if the risk of treatment failure is higher for larger values of V, then we would expect to reject H 0 in favor of H 2 . Thus, the test is useful for evaluating if V is a clinically relevant measure of a treatment's resistance cost (see Gilbert et al., (2000) for a discussion of relevant resistance cost metrics). Knowledge of clinically meaningful genetic resistance cost metrics would be helpful for identifying combination drug regimens that do not select for drug resistant virus, and thus provide long-lasting treatment efficacy.
A second example in which the proposed approach would be of interest is a prospective cohort study of a population at risk for acquiring HIV infection. In this application, T is the time from cohort entry until HIV infection, and V is the value of a metric measuring genotypic or phenotypic dissimilarity of the HIV virus that infects a study participant from a reference HIV strain. For example, V could be Hamming's genetic distance and the reference strain could be the prototype virus contained in an HIV vaccine that is under development for field testing in the cohort population. The test of H 0 versus the two-sided hypothesis H 3 assesses whether the HIV metric V is associated with the instantaneous risk of HIV infection. Finding evidence for H 3 may suggest that the metric V can be used to guide selection of the types of HIV antigens to include in HIV vaccines (Gilbert et al., 2001b) . For example, if H 0 is rejected and the infection risk appears particularly high for v > 0:7, then it may behoove vaccine researchers to insert HIV antigens characterized by v > 0:7. Carrying out the test for multiple metrics in multiple genes could help identify the metric(s) that optimize the breadth of expected protective coverage of the vaccine. This application is important because the broad genotypic and phenotypic diversity of HIV poses one of the greatest challenges to developing an effective AIDS vaccine (UNAIDS, 2001) .
In the case of a discrete mark variable, tests for comparing mark-specific hazards can be found in the literature on competing risks, see, e.g., Aly, Kochar and McKeague (1994) , Sun and Tiwari (1995) , Lam (1998) , Hu and Tsai (1999) , Luo and Turnbull (1999) and Sun (2001) . Fine (1999) developed a semiparametric regression method for competing risks data in which a discrete mark V was used to stratify the effects of other covariates. This approach could not be used directly for continuous marks because the subgroup with a given mark V ¼ v would be empty or contain one subject. Nevertheless, this work suggests that one may explicitly model the effect of continuous mark V on the cumulative incidence function or mark-specific hazard rate. As mentioned earlier, our testing procedure can be viewed as a continuous extension of the procedure of Aly, Kochar and McKeague (1994) and Sun (2001) . To the best of our knowledge, however, these tests have not been developed for continuous mark variables. A nonparametric estimator of the joint distribution of a failure time and a failure mark which may be continuous has been introduced by Huang and Louis (1998) , with a view to applications such as evaluating the relationship between a quality of life score and survival time (Olschewski and Schumacher, 1990) , or between lifetime medical cost and survival time. Their estimator could be used to test whether T and V are independent by comparing it with the product of its marginals. A test statistic based on this approach would have a complex asymptotic distribution, however, and it is not clear that a tractable testing procedure could be formulated. Furthermore, given the interpretability of the mark-specific hazard function in terms of the instantaneous risk of failure, we argue that in some biomedical problems testing kðt; vÞ independent of v is more directly relevant than testing T and V independent. For example, for an HIV infected patient receiving effective antiretroviral treatment at a given time, the risk of treatment failure over the next month is of primary clinical interest, and is measured by the hazard function; accordingly the relationship between the mark variable and the hazard function is of direct clinical interest.
In the case of finitely many causes of failure, test statistics can be based on differences between Nelson-Aalen estimators of the cumulative cause-specific hazard functions, see Sun (2001) . Generalizing this approach, our test procedure is based on estimates of the doubly cumulative mark-specific hazard function Kðt; vÞ ¼ R v 0 R t 0 kðs; uÞ ds du; estimation of this function was also used in a fundamental way by Huang and Louis (1998) . The idea of our testing procedure is to compare a nonparametric estimate of Kðt; vÞ with an estimate under H 0 . We show that the comparison can be weighted to make the test statistics asymptotically distribution-free.
This article is organized as follows. In Section 2 we introduce the test statistics and describe a Monte Carlo procedure for approximating critical values. In Section 3 we derive the asymptotic null distributions of the test statistics, and show that the Monte Carlo-derived critical values are asymptotically accurate. The results of a simulation study and the AIDS clinical trial example are presented in Sections 4 and 5, and proofs of results are given in Appendix A.
Test Procedure
Given observation of i.i.d. replicates (X i 
where YðtÞ ¼ P n i¼1 IðX i ! tÞ is the size of the risk set at time t, and
is the marked counting process with jumps at the uncensored failure times X i and associated marks V i , cf. Huang and Louis (1998, is formed by stratifying on the covariate, which TESTS FOR CONTINUOUS MARKS cannot be done on the mark for competing risks data since the mark is not observed under censoring. The risk set at time t for the competing risks data cannot be stratified by the marks since they are not available until the failures are observed. Although the current approach could be used to test for independence between a failure time and a covariate, it would be more appropriate to use the test of McKeague, Nikabadze and , leading to a stronger conclusion when the null hypothesis is rejected. We also note here in passing that it is important to distinguish a mark variable from a 'marker'; the latter term is synonymous for 'covariate' in the survival analysis literature.
Because H 
Test Processes and Test Statistics
We consider test processes of the form
for t ! 0, 0 v 1, where H n ðÁÞ is a suitable weight process. The weight process H n ðÁÞ provides a flexible way to specify the relative importance attached to differences in the mark-specific hazards at different times, and is useful for controlling instability in the tails. The bivariate test process L n ðt; vÞ is similar to the univariate test process L n ðtÞ used by Aly, Kochar and McKeague (1994, p. 996 ) for comparing two competing risks 1 and 2, given by L n ðtÞ ¼
the cause-j-specific Nelson-Aalen estimator.
Let yðtÞ ¼ PðX ! tÞ ands ¼ supft : yðtÞ > 0g and assume s <s. We propose the following test statistics to measure departures from H 0 in the direction of H 1 , H 2 and H 3 :
If the marks are discretized into K groups by stratifying the marks into K intervals of equal length, the proposed tests reduce to the tests of Aly, Kochar and McKeague (1994) for K ¼ 2 and are equivalent to the tests developed by Sun (2001) . However, the tests using discrete marks could have nearly zero power to detect certain alternatives when the underlying marks are continuous. This point will be discussed further following Theorem 3 on the omnibus property of the proposed tests.
In the next section we show that L n ðt; vÞ converges weakly to a Gaussian process under H 0 . We also show that the proposed tests based on the U j are consistent against their respective alternatives. Since each U j is a continuous functional of L n ðt; vÞ, its limiting null distribution is the distribution of the corresponding functional of the limiting Gaussian process. These distributions are intractable, however, so the critical values of the U j need to be determined using a simulation procedure.
Monte Carlo Procedure
The procedure is based on a randomized version U Ã j of U j defined by replacing each
This yields a randomized version of the test process given by
vÞ. Exploiting the property that T and V are independent and V is uniformly distributed over [0, 1] under H 0 , in Section 3 we show that the null distribution of U j coincides in the limit with the conditional distribution of U Ã j given the observed data. Therefore a critical value of U j can be approximated via a Monte Carlo estimate of the quantile of U Ã j corresponding to a given level of the test.
Choice of Weight Process and a Graphical Procedure
The simplest weight process, H n ðtÞ ¼ 1, yields a test process equal to a normalized difference of estimated doubly cumulative mark-specific hazard functions evaluated at v and at 1:
This process is useful for a graphical procedure, in which the surface L n ðt; vÞ is plotted together with 10 or 20 realizations of the simulated null surface L Ã n ðt; vÞ. Relative to the reference processes L Ã n ðt; vÞ, large values of curvature of L n ðt; vÞ in v suggest H 1 , an increasing trend of this curvature with time suggests H 2 , and absolute differences in L n ðt; vÞ over different mark values suggest H 3 . The graphical procedure is illustrated in the example given in Section 5.
To give the tests maximal power, the weight process should be chosen to downweight the comparison of mark-specific hazards at larger times, where the test process is most variable. A weight process that accomplishes this is given by
T ðtÞ, where b S C and b S T are the Kaplan-Meier estimators of S C and S T , respectively, S C being the survivor function of C. As shown in the next section, this weight process has the added advantage of making the test statistics asymptotically distribution-free.
Large-sample Results
We begin by defining notation that is used in the sequel. Let cðt; vÞ ¼ PðX t; d ¼ 1; V vÞ. By the Glivenko-Cantelli Theorem, Nðt; vÞ=n and YðtÞ=n converge almost surely to cðt; vÞ and yðtÞ, uniformly in ðt; vÞ 2 ½0; 1Þ Â ½0; 1 and t 2 ½0; 1), respectively. Let DðIÞ be the Skorohod space for a k-dimensional rectangle I (Bickel and Wichura 1971) , and CðIÞ be the subspace of continuous functions on I. Also, let x^y and x _ y denote the minimum and maximum of x and y, respectively.
Our first result describes the limiting null distribution of the test process.
THEOREM 
; 1, such that H 2 holds with strict inequality, HðtÞ and R v 0 kðt; uÞ du are continuous in t in a neighborhood of t 0 , and Hðt 0 Þ > 0, then the test based on U 2 is consistent against H 2 . (c) If kðt; vÞ and kðtÞ are continuous on ½0; s Â ½0; 1 and ½0; s, respectively, and HðtÞ ! c > 0 on ½0; s; then the test based on U 3 is consistent against H 3 .
In practice, one may conveniently discretize the marks and apply the tests in Aly, Kochar and McKeague (1994) and Sun (2001) . We caution that such procedures could have nearly zero power to detect certain alternatives for the underlying continuous marks. For instance, if the marks are grouped into two categories with V ¼ 0:25 for those in the interval (0, 0.5) and V ¼ 0:75 for those in the interval (0.5, 1), then the test statistics U 1 , U 2 and U 3 reduce to the tests of Aly, Kochar and McKeague (1994) . Let H n ðtÞ ¼ 1 and choose a model with continuous mark such that R 0:75 0:25 kðt; uÞ du À 0:5kðtÞ ¼ 0 for all t, but kðt; vÞ 6 ¼ kðtÞ. This equation is equivalent to R 0:75 0:25 fðt; uÞ du À 0:5f T ðtÞ ¼ 0 for all t, but fðt; vÞ 6 ¼ f T ðtÞ. A simple example of such alternative is that fðt; vÞ ¼ f T ðtÞf V ðvÞ with f V ðvÞ ¼ 1 À d þ 4dðv À 0:5Þ for v 2 ð0:5; 1Þ and f V ðvÞ ¼ 1 À d À 4dðv À 0:5Þ for v 2 ð0; 0:5Þ, where 0 d 1. This alternative approaches the null hypothesis as d ! 0. It follows from the proof of Lemma 1 that cðds; vÞ À vcðds; 1Þ ¼ PðC ! sÞ½ R v 0 fðs; uÞ du À vf T ðsÞ ds. By Proposition 2 in the Appendix A, under such alternatives, we have L n ðt; 0:75ÞÀ L n ð0:25Þ À! D ½ R t 0 yðsÞ À1 ðG 1 ðds; vÞÀ vG 1 ðds; 1ÞÞ v¼0:75 v¼0:25 , whose distribution can be arbitrarily close to the corresponding null distribution with the uniform marginal for V as d ! 0. This example shows that the test based on U 3 under discretized marks can have nearly zero large-sample power for certain alternatives involving continuous marks. The same conclusion can be reached for U 1 and U 2 .
We now show that the test statistics are asymptotically distribution-free when given the weight process H n ðtÞ ¼ b 
, and Kðt; vÞ is a Kiefer process with CovðKðs; uÞ; Kðt; vÞÞ ¼ ðs^tÞðu^v À uvÞ. Therefore, the e U j are asymptotically distribution-free test statistics. The asymptotic critical values of the tests e U j can be tabulated through a single simulation study based on the known properties of the Kiefer process. This asymptotic distribution-free procedure, which applies only for the weight process
T ðtÞ, is computationally more efficient and provides a good alternative for large sample sizes. However, the proposed Monte Carlo procedure can be used for a broad class of weight processes, it provides more accurate critical values for moderate sample sizes, and it is not overly cumbersome computationally.
Remark 1. In some applications, it is of interest to evaluate whether the instantaneous or absolute risk of failure depends on a continuous mark variable in a given time interval, say ½t 1 ; t 2 Þ, rather than over the entire time range [0, s). The null and alternative hypotheses, and the test statistics U 1 , U 2 , and U 3 , can be modified straightforwardly to address this problem. All of the results given in this section carry over to this case, by replacing [0, s) everywhere with [t 1 , t 2 ). In addition, the results continue to hold if the time range [0, s) is replaced with the possibly larger range [0,s); see the remark following the proof of Theorem 2 in the Appendix A.
Simulation Results
We describe results of a simulation study of the test statistics e U 1 , e U 2 and e U 3 . First we consider a case with T and V independent. The cumulative incidence function is then Fðt; vÞ ¼ PfT tgf V ðvÞ, where f V is the density of V. We specify T to be exponential with mean 1, and f V ðvÞ ¼ ð1=bÞv ð1=bÞÀ1 for 0 v 1. Here b ¼ 1:0 corresponds to the null hypothesis H 0 and b ¼ 0:75, 0.5, 0.25 correspond to three different alternative hypotheses under the monotone alternatives H 1 and H 2 . The extent of departure from the null hypothesis increases as b decreases. We also consider a two-sided alternative with f V ðvÞ ¼ 12ðv À 0:5Þ 2 , 0 v 1 (results in this case are given under the heading 'two-sided' in Tables 1 and 2 ). Next, we consider a case with T and V dependent. For the monotone alternatives H 1 and H 2 , we use
for 0 v 1 and b ¼ 0:5 and 0:25. For a two-sided alternative, we select V from uniform (0, 1) and Fðt; vÞ ¼ 1 À expðÀv 4 tÞ.
We choose n ¼ 50, 100 and use a 30% censoring rate for the failure times. The sizes and powers of the tests are calculated based on 1000 samples. The nominal level is set at 0.05 in each case. The critical level for each test is calculated using 1000 independent replicates of fV Ã 1 ; . . . ; V Ã n g. The results in Table 1 indicate that the proposed tests perform well at moderate sample sizes. The estimated sizes are all within 1.5% of the nominal 5.0% (range: 3.9%-6.5%), and the estimated powers are high for detecting b ¼ 0:25 when n ¼ 50 (range: 81.3%-100.0%) and for detecting b ¼ 0:50 when n ¼ 100 (range: 72.0%-86.6%).
To this point, we have assumed that T and V are jointly continuous. In some applications, however, some ties may be present in the data. To study the sensitivity of the tests to the presence of ties, we use the same simulated data that yielded Table  1 , and group the failure times into 25 tied values x m ¼ 0:05 þ 0:1ðm À 1Þ for and V) , and group the failure marks into 20 tied values v m ¼ 0:025 þ 0:05ðm À 1Þ for 0:05ðm À 1Þ < v 0:05m, m ¼ 1; . . . ; 20. As mentioned earlier, this testing procedure for the tied mark data is equivalent to the procedure of Sun (2001) . The sizes and powers of the tests for the grouped data at a 30% censoring rate and the 5.0% nominal level are given in Table 2 . We note that the presence of ties causes a slight but consistent decrease in the power of the tests, and the levels become more conservative than in the untied case. The test based on e U 3 is quite conservative for tied data, with estimated size 1.8% when n ¼ 50. The test becomes less conservative when the sample size is increased to n ¼ 100, with estimated size 3.3%. An additional simulation (not reported here) shows that, as might be expected, the tests have decreasing power as the number of groups decreases. The slightly larger sizes for n ¼ 100 compared with n ¼ 50 in Table 1 may be due to Monte Carlo error: The reported sizes are the proportion of rejections of H 0 in 1000 samples, so they have a Monte Carlo standard error of about ½0:05 Ã 0:95= 1000 1=2 Â 100% ¼ 0:7%.
Application
In 1995 and 1996, the Adult AIDS Clinical Trials Group (AACTG) conducted a randomized trial (Study 241) of 400 HIV infected adults to evaluate two combination antiretroviral treatments by their ability to suppress HIV viral load (D'Aquila et al., 1996) . The drug regimens contained zidovudine and didanosine plus either nevirapine or nevirapine placebo. Gilbert et al. (2000) analyzed the data from this trial with the failure time T defined as the time from randomization until plasma HIV levels rose above 1000 copies/ml. The available genotypic data from the study are the amino acids at 19 codons in the reverse transcriptase of HIV isolated from peripheral blood mononuclear cells at baseline and at or after the time of failure from 12 patients on the dual-drug arm and 33 patients on the triple-drug arm who failed. The 19 codons were chosen on the basis of information from published studies that mutations in these positions confer resistance to at least one of the studied drugs . For the present analysis, codons with a resistance mutation are coded as ones while codons with nonresistant (whether wildtype or variant) or ambiguous amino acids are coded as zeros.
Let V b be the mutational distance of a subject's virus sequence measured at baseline relative to the 'wildtype' virus with no mutations, defined by
where the weight w i measures the amount of resistance conferred by a mutation at the ith position, as measured by a drug resistance assay. Define V f similarly for a subject's virus sequence measured at or after the time of failure (we refer to this time as the 'late week'). Then, we take V ¼ V f À 2 3 V b as the measure of acquired mutational distance during the trial, which emphasizes new mutations more than baseline mutations. The weights fw i g are taken to be those used by Gilbert et al. (2000) . Note that V is only defined and measured on subjects who fail treatment, and therefore is 
The mark V is the scaled weighted sum of indicators of zidovudine or didanosine resistance mutations at positions 41, 65, 67, 69, 70, 74, 210, 215, and 219 in the reverse transcriptase gene, and of the nevirapine resistance mutations at positions 98, 100, 101, 103, 106, 108, 179, 181, 188, and 190 in the reverse transcriptase gene. Details about the types of mutations, including the selected weights based on the level of in vitro drug susceptibility, can be found in Gilbert et al. (2000) . appropriately viewed as a mark accompanying failure events rather than as a covariate. In the analysis we consider both treatment arms in a single group. Pooling the arms is meaningful because the accumulated resistance metric V is relevant for both arms, as they share the nucleoside inhibitors zidovudine and didanosine.
As depicted in Figure 1 , the mutational distance at baseline V b ranges between 0.0 and 0.187 in the 45 subjects who failed treatment, and increases to 0.0-0.435 by the late week, indicating a trend of increase in mutational distance during the trial. The observed mark variable V takes 28 unique values for the 45 failures, ranging from 0.0 to 0.358, and appears to be approximately uniformly distributed (Figure 1(c) ). A scatterplot of the mark versus failure time does not reveal a systematic pattern . Accumulated mutational distance V versus failure time, for the 45 subjects in clinical trial AACTG Study 241 who failed antiretroviral therapy. The line in the plot is a lowess curve that smooths the data in windows that contain two-thirds of the nearest data-points.
( Figure 2) . To implement the tests, we first normalize V by its maximum observed value (0.358).
The tests confirm what is suspected from the descriptive plots, yielding nonsignificant results for the three alternative hypotheses, with test statistics e U 1 ¼ 0:628 ðP ¼ 0:59Þ, e U 2 ¼ 0:487 ðP ¼ 0:64Þ and e U 3 ¼ 0:353 ðP ¼ 0:76Þ. We next implement the graphical procedure, which uses a unit weight process H n ðtÞ ¼ 1 in the test process L n ðt; vÞ (as in (10)). When comparing the surface L n ðt; vÞ to eight simulated surfaces L Ã n ðt; vÞ (Figure 3) , they appear similar except that L n ðt; 0Þ rises above zero for increasing t while the processes L Ã n ðt; 0Þ tend to remain closer to zero. Other than this caveat, which can be explained by the fact that four trial participants had a tied mark value V ¼ 0, the graphical comparison suggests that the observed test process does not behave unusually compared to the behavior expected under the null hypothesis. We conclude that there is no evidence that the instantaneous or absolute TESTS FOR CONTINUOUS MARKS 481 481 risk of virological failure depends on the level of the resistance mutational distance variable V as defined above. Thus, V may not be useful as a marker of drug resistance. It would be of interest to apply the testing procedure for several other metrics V, as an exploratory search for marks that indicate drug resistance.
Concluding Remarks
The problem addressed here, evaluating whether there is a significant association between the instantaneous or absolute risk of failure and a continuous mark variable observed only at uncensored failure times, has broad application. The two cited applications in AIDS research, in which a time to disease or infection is measured and the mark describes a feature of the agent that causes or is associated with the failure event, arises in many biomedical applications. For one non-AIDS example, in studies evaluating survival of cancer patients, tumor mass might be measured in patients at baseline and at the time of death, and the tests can be used to evaluate a possible association between the growth rate of the tumor and the risk of death. In addition to many other biomedical applications, including the aforementioned problems of assessing the relationship between the risk of death and a quality of life score or a lifetime medical cost, there are a broad variety of applications in other scientific fields. Advantages of the tests developed here for addressing these problems include that they are based on a nonparametric maximum likelihood estimator which is a continuous generalization of the widely applied and well-understood discrete cause-specific Nelson-Aalen estimator, and they are asymptotically distribution-free.
Proof: Let F C ðtÞ be the distribution function of the censoring variable C. Recalling the notation fðt; vÞ for the joint density of ðT; VÞ, we have 
First, we show that the map / is Hadamarddifferentiable tangentially to the set D 0 at every point (A, B) such that 1=BðtÞ is of bounded variation. Let t n ! 0 be any converging sequences and let ða n ; b n Þ ! ða; bÞ 2 D 0 such that ðA þ t n a n ; B þ t n b n Þ 2 D / . Then t À1 n ð/ðA þ t n a n ; B þ t n b n Þðt; vÞ À /ðA; BÞðt; vÞÞ
BðsÞ þ t n b n ðsÞ a n ðds; vÞ À where the limit is obtained by applying a lemma of Bilias, Gu and Ying (1997 To establish the conditional weak convergence of L Ã 1 ðt; vÞ, we shall show that the finite dimensional distributions of L Ã 1 ðt; vÞ converge weakly to those of L 1 ðt; vÞ given the data sequence, and that L Ã 1 ðt; vÞ is asymptotically tight given the data sequence; see van der Vaart and Wellner (1996, p. 183) . The former task can be done by a simple application of the central limit theorem. The asymptotic tightness of L Ã 1 ðt; vÞ given the data sequence can be proved by applying the tightness criteria of Bickel and Wichura (1971, equation 3, p. 1658 ) based on neighboring blocks. The details are contained in a technical report that can be requested from the authors. Denote the left and the right side of (A.11) by L a n ðt; vÞ and L a ðt; vÞ, respectively. Then U 1 ¼ sup v1<v2 sup 0 t<s Dðt; v 1 ; v 2 Þ ¼ sup v1<v2 sup 0 t<s ½ðL a n ðt; v 1 Þ þ L a n ðt; v 2 Þ À 2L a n ðt; ðv 1 þ v 2 Þ=2ÞÞ þ ffiffi ffi n p ðmðt; v 1 Þ þ mðt; v 2 Þ À 2mðt; ðv 1 þ v 2 Þ=2ÞÞ ! ffiffi ffi n p sup v1<v2 sup 0 t<s ððmðt; v 1 Þ þ mðt; v 2 Þ À 2mðt; ðv 1 þ v 2 Þ=2ÞÞÞ À sup v1<v2 sup 0 t<s ½ÀðL a n ðt; v 1 Þ þ L a n ðt; v 2 Þ À 2L a n ðt; ðv 1 þ v 2 Þ=2ÞÞ ðA:14Þ where the last inequality is obtained since R v1 0 Fðs; uÞ du þ R v2 0 Fðs; uÞ du À 2 R ðv1þv2Þ=2 0 Fðs; uÞ du ! 0 under H 1 and HðsÞ=S T ðsÞ is decreasing. Under H 1 with the given t 0 such that the inequality of the alternative H 1 holds strictly for some ðv 1 ; v 2 Þ 2 ½0; 1, R v 0 Fðt 0 ; uÞ du is a strictly concave function. Hence for some v 1 , v 2 2 ½0; 1. By Proposition 2, the second term of (A.14) converges in distribution to a finite random variable. This yields U 1 À! P 1. Since U Ã 1 converges in distribution to a finite random variable, U 1 is consistent against H 1 . (b) Note that, for s < t, mðt; v 1 Þ þ mðt; v 2 Þ À 2mðt; ðv 1 þ v 2 Þ=2Þ À mðs; v 1 Þ þ mðs; v 2 Þ À 2mðs; ðv 1 þ v 2 Þ=2Þ À! Under H 2 , with the given t 0 such that the inequality of the alternative H 2 holds strictly for some ðv 1 ; v 2 Þ 2 ½0; 1, R v 0 kðt 0 ; uÞ du is a strictly concave function. Hence Z v1 0 kðt 0 ; uÞ du þ Z v2 0 kðt 0 ; uÞ du À 2 Z ðv1þv2Þ=2 0 kðt 0 ; uÞ du > 0;
for some v 1 , v 2 2 ½0; 1. Following a similar argument as in part (a) of the proof for the consistency of U 1 , applying Proposition 2, and by the continuity assumptions of the theorem, we have U 2 À! P 1. Since U Ã 2 converges in distribution to a finite random variable, U 2 is consistent against H 2 .
(c) Note that the alternative H 3 that kðt; vÞ does not depend on v for all t 2 ½0; s is equivalent to R t 0 HðsÞ R v 0 ðkðs; uÞ À kðsÞÞ du Â Ã ds not depending on v for all t 2 ½0; s. Thus, under H 3 there exists ðt 0 ; v 1 ; v 2 Þ, t 0 2 ½0; s, ðv 1 ; v 2 Þ 2 ½0; 1 such that mðt 0 ; v 2 Þ À mðt 0 ; v 1 Þ À! it follows by Proposition 2, the continuous mapping theorem and (A.15) that U 3 À! P 1 under H 3 . Since U Ã 3 converges in distribution to a finite random variable, U 3 is consistent against H 3 .
Notes

